Study Evaluating the Safety and Tolerability
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Healthy Volunteers
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Adouble-blind, randomised, placebo-controlled, parallel-groupMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: This is a double-blind study and the allocation of treatments will not be disclosed until clean file has been declared and the database has been locked.Primary Purpose: Other
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
The design of the study is based on the aim to study safety and tolerability of B. longum in a limited number of healthy volunteers.
The design of the study is based on the aim to study safety and tolerability of B. longum in a limited number of healthy volunteers.
Tracking Information
- NCT #
- NCT04692506
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Erik Rein-Hedin, MD CTC Clinical Trial Consultants AB Dag Hammarskjölds väg 10B SE-752 37 Uppsala, Sweden
Get Well Soon